170 related articles for article (PubMed ID: 10496354)
1. Proteolysis in human breast and colorectal cancer.
Garbett EA; Reed MW; Brown NJ
Br J Cancer; 1999 Sep; 81(2):287-93. PubMed ID: 10496354
[TBL] [Abstract][Full Text] [Related]
2. Proteolysis in colorectal cancer.
Garbett EA; Reed MW; Brown NJ
Mol Pathol; 1999 Jun; 52(3):140-5. PubMed ID: 10621835
[TBL] [Abstract][Full Text] [Related]
3. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
4. Proteolysis in human breast cancer.
Garbett EA; Reed MW; Stephenson TJ; Brown NJ
Mol Pathol; 2000 Apr; 53(2):99-106. PubMed ID: 10889910
[TBL] [Abstract][Full Text] [Related]
5. The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology.
Baker EA; Leaper DJ
Eur J Cancer; 2003 May; 39(7):981-8. PubMed ID: 12706368
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Baker EA; Bergin FG; Leaper DJ
Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
Kikkawa F
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
[TBL] [Abstract][Full Text] [Related]
8. Expression of proteinases and inhibitors in human breast cancer progression and survival.
Baker EA; Stephenson TJ; Reed MW; Brown NJ
Mol Pathol; 2002 Oct; 55(5):300-4. PubMed ID: 12354933
[TBL] [Abstract][Full Text] [Related]
9. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid.
Baker EA; Leaper DJ
Wound Repair Regen; 2000; 8(5):392-8. PubMed ID: 11115151
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Kossakowska AE; Huchcroft SA; Urbanski SJ; Edwards DR
Br J Cancer; 1996 Jun; 73(11):1401-8. PubMed ID: 8645587
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis.
Li BH; Zhao P; Liu SZ; Yu YM; Han M; Wen JK
World J Gastroenterol; 2005 May; 11(20):3046-50. PubMed ID: 15918187
[TBL] [Abstract][Full Text] [Related]
12. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
Jones JL; Glynn P; Walker RA
J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and their inhibitors.
Kugler A
Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
Işlekel H; Oktay G; Terzi C; Canda AE; Füzün M; Küpelioğlu A
Cell Biochem Funct; 2007; 25(4):433-41. PubMed ID: 16615041
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
[TBL] [Abstract][Full Text] [Related]
16. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm].
Wan Y; Wei Q; Pan Y; Liu Y
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):510-3. PubMed ID: 11832095
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
Collins HM; Morris TM; Watson SA
Br J Cancer; 2001 Jun; 84(12):1664-70. PubMed ID: 11401321
[TBL] [Abstract][Full Text] [Related]
18. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
19. [Significance in gene expression of matrix metalloproteinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colo-rectal cancer].
Koumura H; Sugiyama Y; Kunieda K; Saji S
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():324-31. PubMed ID: 9263524
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis.
Kim YW; Ko YT; Kim NK; Chung HC; Min BS; Lee KY; Park JP; Kim H
Scand J Gastroenterol; 2010; 45(2):217-25. PubMed ID: 20095886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
